NCT06734403

Brief Summary

The goal of this observational study is to analyse the occurence of urinary calculi after bladder augmentation in children:

  • location of the calculi (kidney or bladder)
  • type of bladder augmentation with higher rate of urinary calculi and why
  • Find risk factors of urinary calculi in bladder augmentation (age, sex, other bladder procedures..)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2023

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

December 11, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

December 16, 2024

Completed
Last Updated

December 16, 2024

Status Verified

December 1, 2024

Enrollment Period

2 months

First QC Date

December 11, 2024

Last Update Submit

December 11, 2024

Conditions

Keywords

Urinary CalculusBladder AugmentationChildRetrospective Study

Outcome Measures

Primary Outcomes (2)

  • Rate of participants with urinary calculi

    Rate of participants with urinary calculi After bladder augmentation

    Through study completion, an average of 2 years

  • Location of urinary calculi in the participants

    After bladder augmentation, urinary calculi can be seen on postoperative imaging such as abdominal ultrasound, CT scan, and MRI. The different locations of these calculi can be the kidneys, the ureters, the bladder, or the urethra. Each patient who has had urinary calculi will be reported, and the location of the calculi will be specified depending on the imaging results.

    Through study completion, an average of 2 years

Secondary Outcomes (3)

  • Time frame between surgery and occurence of urinary calculi in the participants After bladder augmentation

    Through study completion, an average of 2 years

  • Management of urinary calculi after bladder augmentation in the participants

    Through study completion, an average of 2 years

  • Risk factors of urinary calculi after bladder augmentation in the participants

    Through study completion, an average of 2 years

Study Arms (2)

Ileocystoplasty

Urinary Calculi After Ileocystoplasty in Children

Other: Bladder Augmentation

Sigmoidocystoplasty

Urinary Calculi After Sigmoidocystoplasty in Children

Other: Bladder Augmentation

Interventions

Bladder Augmentation using bowel loop (ileal or sigmoid loop)

IleocystoplastySigmoidocystoplasty

Eligibility Criteria

Age0 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients younger than 18 years old, with urinary calculi, after bladder augmentation.

You may qualify if:

  • Patients younger than 18 years old, with urinary calculi, after bladder augmentation

You may not qualify if:

  • Patients older than 18 years old, with urinary calculi, after bladder augmentation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital, Clermont-Ferrand

Clermont-Ferrand, Auvergne, 63003, France

Location

MeSH Terms

Conditions

Urinary CalculiUrinary Bladder, NeurogenicSpinal Dysraphism

Condition Hierarchy (Ancestors)

UrolithiasisUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsNeurologic ManifestationsNervous System DiseasesUrinary Bladder DiseasesSigns and SymptomsNeural Tube DefectsNervous System MalformationsCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

December 11, 2024

First Posted

December 16, 2024

Study Start

November 20, 2022

Primary Completion

January 31, 2023

Study Completion

April 10, 2023

Last Updated

December 16, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

In the name of anonymization the investigators won't share individual participant data

Locations